Oncology Chronic Myeloid Leukemia: Current Recommendations for Treatment and Monitoring expert roundtables By Gabriela S. Hobbs, MD; Mark J. Levis, MD, PhD; Neil P. Shah, MD, PhD
Oncology Recommendations for Second-Generation Tyrosine Kinase Inhibitors As Frontline Therapy in the Management of Chronic Myeloid Leukemia patient care perspectives By Mark J. Levis, MD, PhD
Oncology Multiple Myeloma: Immunomodulatory Agents in the Evolving Treatment Paradigm patient care perspectives By Kenneth C. Anderson, MD
Oncology Recommended Maintenance Therapy for Multiple Myeloma: Transplant and Nontransplant Settings expert roundtables By Kenneth C. Anderson, MD; S. Vincent Rajkumar, MD; Sagar Lonial, MD, FACP
Oncology The Evolving Role of Immunomodulatory Agents in Multiple Myeloma expert roundtables By Kenneth C. Anderson, MD; S. Vincent Rajkumar, MD; Sagar Lonial, MD, FACP